Get started
Author

Giulia Bartolini

Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial
2020 · Andrea Casadei Gardini, Emanuela Scarpi, et al. · Therapeutic Advances in Medical Oncology · 38
PDF
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab
2023 · Alessandro Passardi, Irene Azzali, et al. · Therapeutic Advances in Medical Oncology · 23
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer
2023 · Milena Urbini, Giorgia Marisi, et al. · JCO Precision Oncology · 20
PDF
Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer
2021 · Matteo Canale, Manlio Monti, et al. · Cancers · 19
PDF
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients
2021 · Andrea Casadei-Gardini, Roberto Filippi, et al. · Oncology · 18
Aeromonas veronii biovar veronii and sepsis-infrequent complication of biliary drainage placement: A case report
2019 · Manlio Monti, Arianna Torri, et al. · World Journal of Clinical Cases · 17
PDF
The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation
2021 · Margherita Rimini, Pierfrancesco Franco, et al. · Cancers · 13
PDF
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training–Validation Trial
2022 · Alessandro Passardi, Flavia Foca, et al. · Journal of Medical Internet Research · 11
PDF
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value
2023 · Ivan Vannini, Tania Rossi, et al. · Molecular Therapy — Methods & Clinical Development · 10
PDF
Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis
2021 · Ilario Giovanni Rapposelli, Serena De Matteis, et al. · Cancers · 10
PDF
Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer
2021 · Ilario Giovanni Rapposelli, Valentina Zampiga, et al. · BMC Cancer · 6
PDF
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer
2023 · Giorgia Marisi, Irene Azzali, et al. · Scientific Reports · 5
PDF
Posterior reversible encephalopathy syndrome: A rare neurotoxicity after capecitabine
2020 · Manlio Monti, Domenico Barone, et al. · Journal of Oncology Pharmacy Practice · 5
Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
2021 · Paola Ulivi, Alessandro Passardi, et al. · Frontiers in Pharmacology · 4
PDF
Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer
2021 · Ilario Giovanni Rapposelli, Andrea Casadei-Gardini, et al. · Biomolecules · 4
PDF
Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis
2021 · Manlio Monti, Massimo Guidoboni, et al. · Therapeutic Advances in Gastroenterology · 4
Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies
2021 · Alessandro Passardi, Ilario Giovanni Rapposelli, et al. · Biomolecules · 3
PDF
Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination with 5-Fluorouracil in the FOLFIRI Regimen
2021 · Alessandro Passardi, Manlio Monti, et al. · The Oncologist · 3
PDF
Recurrent pneumothorax in a patient with liposarcoma as either a complication of lung micrometastasis or a potential adverse event from antibiotic therapy: A case report
2022 · Manlio Monti, Francesco Sullo, et al. · Oncology Letters · 2
PDF
Abstract 7610: Predictive biomarkers for immuno-chemotherapy response in biliary tract malignancies
2024 · Michele Zanoni, Tania Rossi, et al. · Cancer Research · 1
Use of the ONCO-TreC electronic diary compared with a standard paper diary to improve adherence to oral cancer therapy in patients with solid and haematological tumours: protocol for a randomised controlled trial
2022 · Alessandro Passardi, Patrizia Serra, et al. · BMJ Open · 1
PDF
Innovative pathological and therapeutic approaches for poorly cohesive gastric cancer
2026 · Margherita Muratore, Francesco Giulio Sullo, et al. · Frontiers in Oncology
PDF
P-117 Circulating tumor DNA in metastatic colorectal cancer: Real-time monitoring of disease evolution and treatment response
2022 · G. Marisi, M. Urbini, et al. · Annals of Oncology
Advancing strategies to increase adherence to oral therapies in onco-hematology: a randomized study (Preprint)
2021 · Alessandro Passardi, Patrizia Serra, et al.
PP-040 Evaluation of therapy management for prevention of chemotherapy induced nausea and vomiting in a centralised intravenous compounding facility
2017 · C Bufarini, S Leoni, et al. · European Journal of Hospital Pharmacy
Works count: 31
Citation count: 217
H-index: 10
I10-index: 10
Year
Topic
Type